Jane Street
KURA icon

Jane Street’s Kura Oncology KURA Stock Holding History

Jane Street’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Sell
26,600
-9,300
-26% -$79.9K ﹤0.01% 9969
2025
Q4 		$373K Buy
35,900
+24,600
+218% +$258K ﹤0.01% 8358
2025
Q3 		$100K Buy
+11,300
New +$80.5K ﹤0.01% 10133
2024
Q2 		– Sell
-19,300
Closed -$412K – 9828
2024
Q1 		$412K Buy
+19,300
New +$375K ﹤0.01% 7038
2022
Q1 		– Sell
-13,000
Closed -$182K – 10692
2021
Q4 		$182K Buy
+13,000
New +$211K ﹤0.01% 8882

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's KURA Position: Q1 2026 in Review

Jane Street increased its Kura Oncology (KURA) stake by 39% in Q1 2026, buying an estimated $1.6M and bringing the position to 663,350 shares worth $5.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Jane Street first reported a position in KURA in Q2 2019 and has held it in 23 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Jane Street held 663,350 shares of Kura Oncology worth $5.39M as of Q1 2026.
  • Jane Street bought 186,205 Kura Oncology shares in Q1 2026, an estimated $1.6M.
  • Kura Oncology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3397 holding.
  • Jane Street first reported a position in Kura Oncology in Q2 2019 and has held it in 23 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.